Sumitra Muralidhar

LifeArc — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

36h-index6.6kcitations127works10.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic Associations and Epidemiology(31), Cytomegalovirus and herpesvirus research(9), Viral-associated cancers and disorders(8), Bipolar Disorder and Treatment(7), COVID-19 Clinical Research Studies(6)

Publications106 total

Leveraging large-scale biobanks for therapeutic target discovery
Human Genetics and Genomics Advances·2025Open Access
An African ancestry-specific nonsense variant in CD36 is associated with a higher risk of dilated cardiomyopathy
Nature Genetics·2025· 1 citedOpen Access
Integrative Proteome- and Phenome-Wide Assessment Uncovers Causal Protein Drivers and Drug Targets for Heterogeneous Kidney Diseases
2025Open Access
A genomic-led strategy to anticipate drug safety effects
2025Open Access
Increasing Value in the Veterans Affairs Healthcare System (VA) with Precision Health: A Continuing Landmark Collaboration with the Department of Energy
2025Open Access
A STUDY ON GENERATIONAL DYNAMICS IN ORGANIZATIONS: EXPLORING CO-EXISTENCE AND LEADERSHIP FOR INCLUSIVE GROWTH AND DEVELOPMENT
International Journal of Advanced Research in Commerce Management & Social Science·2025
Primary care providers’ perspectives on receiving opportunistic genomic results from a national study: The Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study
Genetics in Medicine·2025· 1 cited
Leveraging Large-Scale Biobanks for Therapeutic Target Discovery
2025· 3 citedOpen Access
The impact of imprecise case definitions in electronic health record research: a melanoma case-study from the Million Veteran Program
Archives of Dermatological Research·2025
Visualizing Geospatial and Temporal Phenotype Prevalences
2024Open Access
Primary Care Providers’ Perspectives on Receiving Tier 1 Genomic Results from a National Study – the Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study
2024Open Access
A Study on the Plausibility of Financial Distress Due to Covid 19: Evidence from Nifty Fifty Companies
Studies in systems, decision and control·2024
<i>GLP1R</i> Gene Expression and Kidney Disease Progression
JAMA Network Open·2024· 6 citedOpen Access
A landmark federal interagency collaboration to promote data science in health care: Million Veteran Program-Computational Health Analytics for Medical Precision to Improve Outcomes Now
JAMIA Open·2024· 3 citedOpen Access
Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk
Nature Communications·2024· 21 citedOpen Access
Military and occupational exposures among Veterans in the Million Veteran Program by survey self-report: a descriptive study
Occupational and Environmental Medicine·2024· 6 cited
Providers’ use of pharmacogenetic testing to inform opioid prescribing among veterans
Pharmacogenomics·2024Open Access
Biological Insights from Schizophrenia-associated Loci in Ancestral Populations
2024· 4 citedOpen Access
Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol
European Journal of Preventive Cardiology·2024· 13 citedOpen Access
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
Science·2024· 284 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Philip S. Tsao(46), Saiju Pyarajan(35), Kelly Cho(31), J. Michael Gaziano(23), Stacey B. Whitbourne(22), Mary T. Brophy(21), Grant D. Huang(20), John Concato(19), Scott L. DuVall(19), Rachel Ramoni(19), Christopher J. O’Donnell(19), Jennifer Moser(18), Kyong‐Mi Chang(18), Hongyu Zhao(18), Jean C. Beckham(18), Peter W.F. Wilson(16), Yan V. Sun(15), Themistocles L. Assimes(14), Yuk‐Lam Ho(13), Juan P. Casas(13)